Northern Trust Portfolio holdings
Northern Trust Corporation, founded in 1889 and headquartered in Chicago, Illinois, is a prominent financial services firm specializing in wealth management, asset management, and asset servicing for high-net-worth individuals, families, and institutions. Known for its conservative and client-focused approach, it manages hundreds of billions in assets, offering trust and custody services, investment solutions, and banking products tailored to affluent clients and organizations like foundations and endowments. The company has built a reputation for reliability and discretion, serving as a custodian for a significant portion of global institutional assets while maintaining a strong presence in private banking.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Warner Bros
WBD
|
+$380M |
| 2 |
Linde
LIN
|
+$220M |
| 3 |
Dimensional US Marketwide Value ETF
DFUV
|
+$197M |
| 4 |
FlexShares STOXX Global Broad Infrastructure Index Fund
NFRA
|
+$191M |
| 5 |
VICI Properties
VICI
|
+$169M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$939M |
| 2 |
Microsoft
MSFT
|
+$729M |
| 3 |
AT&T
T
|
+$467M |
| 4 |
CERN
Cerner Corp
CERN
|
+$368M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.07% |
| 2 | Healthcare | 14.01% |
| 3 | Financials | 11.93% |
| 4 | Consumer Discretionary | 9.56% |
| 5 | Industrials | 7.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4026
Cue Biopharma
CUE
$113M
| $150K | ﹤0.01% |
2,016
-8,129
| -80% | -$951K |
|
4027
Gyre Therapeutics
GYRE
$641M
| $150K | ﹤0.01% |
11,271
+113
| +1% | +$751 |
|
|
HUYA
4028
Huya Inc
HUYA
$563M
| $150K | ﹤0.01% |
+38,700
| New | +$162K |
|
4029
Townsquare Media
TSQ
$106M
| $150K | ﹤0.01% |
18,351
+450
| +3% | +$4.66K |
|
|
AMTI
4030
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
| $150K | ﹤0.01% |
51,361
-183,741
| -78% | -$772K |
|
4031
EVI Industries
EVI
$181M
| $149K | ﹤0.01% |
14,897
-30,699
| -67% | -$409K |
|
4032
GEE Group
JOB
$23.1M
| $149K | ﹤0.01% |
286,374
+266
| +0.1% | +$153 |
|
4033
Loop Industries
LOOP
$35.3M
| $149K | ﹤0.01% |
38,451
-8,516
| -18% | -$52.8K |
|
|
NNDM
4034
Nano Dimension
NNDM
$316M
| $149K | ﹤0.01% |
47,283
-500
| -1% | -$1.48K |
|
4035
PDS Biotechnology
PDSB
$38.4M
| $148K | ﹤0.01% |
40,514
-1,306
| -3% | -$6.21K |
|
|
HGEN
4036
DELISTED
HUMANIGEN, INC.
HGEN
| $148K | ﹤0.01% |
83,734
-360,510
| -81% | -$809K |
|
4037
Cardiff Oncology
CRDF
$66.5M
| $147K | ﹤0.01% |
66,592
-251,266
| -79% | -$421K |
|
|
BIOR
4038
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
| $147K | ﹤0.01% |
840
| – | – |
|
4039
Celestica
CLS
$38.1B
| $146K | ﹤0.01% |
15,000
| – | – |
|
4040
INNOVATE Corp
VATE
$111M
| $146K | ﹤0.01% |
8,466
-31,571
| -79% | -$864K |
|
4041
Barings BDC
BBDC
$864M
| $145K | ﹤0.01% |
15,577
+1,900
| +14% | +$19.3K |
|
4042
Arq
ARQ
$84.6M
| $145K | ﹤0.01% |
30,919
-517
| -2% | -$2.81K |
|
4043
Stereotaxis
STXS
$126M
| $144K | ﹤0.01% |
78,368
-347,229
| -82% | -$830K |
|
4044
Taysha Gene Therapies
TSHA
$1.68B
| $144K | ﹤0.01% |
38,821
-166,804
| -81% | -$662K |
|
|
AIOT
4045
PowerFleet Inc
AIOT
$526M
| $144K | ﹤0.01% |
66,271
| – | – |
|
4046
Harmony Gold Mining
HMY
$9.84B
| $143K | ﹤0.01% |
45,697
-1,960
| -4% | -$7.54K |
|
|
GLS
4047
DELISTED
Gelesis Holdings, Inc.
GLS
| $143K | ﹤0.01% |
92,591
+52,951
| +134% | +$219K |
|
4048
Everspin Technologies
MRAM
$341M
| $142K | ﹤0.01% |
27,008
| – | – |
|
4049
Orion Group Holdings
ORN
$396M
| $142K | ﹤0.01% |
62,393
-1,448
| -2% | -$3.73K |
|
|
MACK
4050
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $142K | ﹤0.01% |
23,803
-1,260
| -5% | -$7.11K |
|
Similar funds
Northern Trust's Q2 2022 Portfolio in Review
As of Q2 2022, Northern Trust held 4,878 positions worth $467B, down 18% from $568B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Northern Trust's Q2 2022 filing shows 136 new, 1,684 increased, 2,550 reduced and 129 closed positions. Its largest new stake was Dimensional US Marketwide Value ETF: 5,908,514 shares worth $187M. The largest sale was Apple, an estimated $939M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
- Northern Trust's largest Q2 2022 buy was Dimensional US Marketwide Value ETF: 5,908,514 shares worth $187M.
- Northern Trust added most to Warner Bros in Q2 2022, an estimated $380M increase.
- Northern Trust's biggest Q2 2022 reduction was Apple, cutting an estimated $939M.
- Northern Trust fully exited Cerner Corp in Q2 2022, selling an estimated $368M.
- Northern Trust's ten largest holdings make up 21% of its $467B portfolio in Q2 2022.
- Northern Trust opened 136 new positions and closed 129 in Q2 2022.
- Northern Trust's portfolio value fell 18% quarter-over-quarter to $467B.
Based on Northern Trust's 13F filing for Q2 2022, filed 12 Aug 2022.